MedCrypt Expands Cybersecurity Partnerships with Diabetes Technology Companies
MedCrypt is working with six diabetes care technology providers to offer cybersecurity services for next-generation diabetes technologies.
MedCrypt is working with six diabetes care technology providers to offer cybersecurity services for next-generation diabetes technologies.
The warning letter from the FDA is related to recalls of the MiniMed 600 series insulin infusion pump, and a device for MiniMed 508 and Paradigm pumps.
MedCrypt is working with six diabetes care technology providers to offer cybersecurity services for next-generation diabetes technologies.